Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions MC Callegan, M Engelbert, DW Parke, BD Jett, MS Gilmore Clinical microbiology reviews 15 (1), 111-124, 2002 | 445 | 2002 |
Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection RJ O'Callaghan, MC Callegan, JM Moreau, LC Green, TJ Foster, ... Infection and immunity 65 (5), 1571-1578, 1997 | 239 | 1997 |
Pathogenesis of gram-positive bacterial endophthalmitis MC Callegan, MC Booth, BD Jett, MS Gilmore Infection and immunity 67 (7), 3348-3356, 1999 | 202 | 1999 |
Bacterial endophthalmitis: therapeutic challenges and host–pathogen interactions MC Callegan, MS Gilmore, M Gregory, RT Ramadan, BJ Wiskur, ... Progress in retinal and eye research 26 (2), 189-203, 2007 | 191 | 2007 |
Clonal Associations among Staphylococcus aureus Isolates from Various Sites of Infection MC Booth, LM Pence, P Mahasreshti, MC Callegan, MS Gilmore Infection and Immunity 69 (1), 345-352, 2001 | 185 | 2001 |
Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis MC Callegan, LS Engel, JM Hill, RJ O'Callaghan Infection and Immunity 62 (6), 2478-2482, 1994 | 182 | 1994 |
Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis MC Booth, AL Cheung, KL Hatter, BD Jett, MC Callegan, MS Gilmore Infection and immunity 65 (4), 1550-1556, 1997 | 169 | 1997 |
Role of Hemolysin BL in the Pathogenesis of Extraintestinal Bacillus cereus Infection Assessed in an Endophthalmitis Model MC Callegan, BD Jett, LE Hancock, MS Gilmore Infection and immunity 67 (7), 3357-3366, 1999 | 135 | 1999 |
Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. RJ O'Callaghan, LS Engel, JA Hobden, MC Callegan, LC Green, JM Hill Investigative ophthalmology & visual science 37 (4), 534-543, 1996 | 135 | 1996 |
Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens MC Callegan, R Ramirez, ST Kane, DC Cochran, H Jensen Advances in therapy 20, 246-252, 2003 | 113 | 2003 |
Hypermucoviscosity as a virulence factor in experimental Klebsiella pneumoniae endophthalmitis BJ Wiskur, JJ Hunt, MC Callegan Investigative ophthalmology & visual science 49 (11), 4931-4938, 2008 | 108 | 2008 |
Relationship of plcR-Regulated Factors to BacillusEndophthalmitis Virulence MC Callegan, ST Kane, DC Cochran, MS Gilmore, M Gominet, D Lereclus Infection and Immunity 71 (6), 3116-3124, 2003 | 108 | 2003 |
Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis RT Ramadan, R Ramirez, BD Novosad, MC Callegan Current eye research 31 (11), 955-965, 2006 | 94 | 2006 |
Bacillus endophthalmitis: roles of bacterial toxins and motility during infection MC Callegan, ST Kane, DC Cochran, B Novosad, MS Gilmore, M Gominet, ... Investigative ophthalmology & visual science 46 (9), 3233-3238, 2005 | 81 | 2005 |
Severe bacterial endophthalmitis: towards improving clinical outcomes BD Novosad, MC Callegan Expert review of ophthalmology 5 (5), 689-698, 2010 | 79 | 2010 |
Contribution of Membrane-Damaging Toxins to Bacillus Endophthalmitis Pathogenesis MC Callegan, DC Cochran, ST Kane, MS Gilmore, M Gominet, D Lereclus Infection and immunity 70 (10), 5381-5389, 2002 | 70 | 2002 |
Methicillin resistance of Staphylococcus species among health care and nonhealth care workers undergoing cataract surgery R Olson, E Donnenfeld, FA Bucci Jr, FW Price Jr, M Raizman, K Solomon, ... Clinical Ophthalmology, 1505-1514, 2010 | 69 | 2010 |
Bacillus cereus–induced permeability of the blood–ocular barrier during experimental endophthalmitis AL Moyer, RT Ramadan, BD Novosad, R Astley, MC Callegan Investigative ophthalmology & visual science 50 (8), 3783-3793, 2009 | 68 | 2009 |
Virulence factor profiles and antimicrobial susceptibilities of ocular Bacillus isolates MC Callegan, DC Cochran, ST Kane, RT Ramadan, J Chodosh, ... Current eye research 31 (9), 693-702, 2006 | 65 | 2006 |
Pseudomonas deficient in protease IV has significantly reduced corneal virulence. LS Engel, JA Hobden, JM Moreau, MC Callegan, JM Hill, RJ O'Callaghan Investigative ophthalmology & visual science 38 (8), 1535-1542, 1997 | 65 | 1997 |